96568-35-3

Usage

Uses

Used in Pharmaceutical Industry:
1-Benzyl-3-(methylamino)pyrrolidine is used as an intermediate in the synthesis of pharmaceuticals for its potential role in the development of antipsychotic and antidepressant drugs. Its unique structure allows it to serve as a building block in the creation of these medications, contributing to their therapeutic effects.
Used in Organic Synthesis:
In the field of organic synthesis, 1-benzyl-3-(methylamino)pyrrolidine is utilized as a versatile building block for the production of other chemical compounds. Its presence in various chemical reactions can lead to the formation of new molecules with different applications across various industries.

InChI:InChI=1/C12H18N2/c1-13-12-7-8-14(10-12)9-11-5-3-2-4-6-11/h2-6,12-13H,7-10H2,1H3

Upstream product

• 775-16-6 N-benzyl-3-pyrrolidinone 
• 74-89-5 methylamine 
• 10603-52-8 1-benzyl-pyrrolidine-3-carbonitrile 

Downstream Products

• 79286-87-6 (RS)-3-(acetyl-methyl-amino)-pyrrolidine 
• 172477-98-4 1-benzyl-3-<(t-butyloxycarbonyl)methylamino>-pyrrolidine 
• 1359951-10-2 N-(1-benzylpyrrolidin-3-yl)-4-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-N-methyl-6-morpholin-4-ylpyrimidin-2-amine hydrochloride 
• 1353996-41-4 3-(Methylamino)-1-acetylpyrrolidine 
• 172478-04-5 3-methylamino-1-propionyl-pyrrolidine 
• 169750-01-0 3-<(t-butyloxycarbonyl)methylamino>-pyrrolidine 
• 172477-94-0 1-benzyl-3-methylpropionylamino-pyrrolidine 

Relevant academic research and scientific papers

Antibacterial compounds

Bacterial protein synthesis-inhibiting compounds having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the compounds are disclosed.

Monocyclic Analogues of the μ-Opioid Agonist 3,8-Diazabicyclooctanes: Synthesis, Modeling, and Activity

Several monocyclic derivatives structurally related to the μ-opioid agonist 3-cinnamyl-8-propionyl-3,8-diazabicyclooctane have been synthesized and tested in binding studies using the μ-selective 3H-DAMGO as ligand.Modeling studies have been performed on the same compounds in order to explain the observed lack of affinity towards μ-opioid receptors.

Antibacterial 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives

The present invention relates to a 1,8-naphthyridine derivative of the formula STR1 wherein R1, R2 and R3 are the same or different and each hydrogen or lower alkyl having 1 to 5 carbon atoms; and esters thereof and salts thereof and processes for preparation thereof. These compounds show excellent antibacterial activity and are useful antibacterial agents.